Latest: Bench calls hospital drug margins 'loot' and 'dacoity' as it reserves order on medicine pricing petitions
A Supreme Court bench of Justices Vikram Nath and Sandeep Mehta heard petitions on medicine pricing on Tuesday and reserved its order. It asked why the system seemed to favour manufacturers, called the National Pharmaceutical Pricing Authority 'totally defunct', and described excessive hospital margins as 'loot' and 'dacoity', citing a chemotherapy injection billed at Rs 1.30 lakh against a dealer price of Rs 11,000.
The Centre defended selective intervention, a 30 per cent cap on cancer drug trade margins and its claim that Indian prices are among the world's lowest, and said higher margins help medicines reach far-flung areas. Private hospitals argued they need their own pharmacies, and one petition seeks mandatory generic prescriptions and statutory margin caps. Summary updated 28 Oct, 19:31 IST
Why it matters: Medicine costs make up a significant share of treatment spending for Indian families, so any ruling on pricing and margins could affect what patients pay.
Winding down: no new coverage since 28 Oct. It will be archived on 4 Nov unless new coverage appears.
This matter is before the courts or under investigation. Nazariya reports what was said and alleged; it does not decide guilt or the outcome.
New developments are added here, newest first. When the headline, summary or other sections change, the earlier version is kept under “See earlier version”.
Headline before this update: Supreme Court questions medicine price control gaps, reserves order
Summary before this update: A Supreme Court bench of Justices Vikram Nath and Sandeep Mehta heard petitions on medicine pricing on Tuesday. It questioned the gap between MRP and retailer prices, asked why most medicines are kept out of price control and why the Centre took so long to cap cancer drug margins, citing a chemotherapy injection billed at Rs 1.30 lakh against a dealer price of Rs 11,000. It called the National Pharmaceutical Pricing Authority 'totally defunct' and reserved its order. The Centre defended its policy of selective intervention and its 30 per cent cap on cancer drug trade margins, and private hospitals argued they need their own pharmacies.
Note before this update: All six outlets are critical of the Centre's handling and stress the court's sharp questions, but they differ in emphasis: the Centre's defence, price gaps, hospital arguments, the delay in the cap and the scope of price control.
“What's missing” before this update:
Based on 8 articles read in full. Scores describe each article's framing, not the outlet and not whether it is accurate.
Large outlets read: 4 of 15 (Hindustan Times, Aaj Tak, Times Now, Dainik Bhaskar).
All eight outlets are critical of the Centre's handling and stress the court's sharp questions, but they differ in emphasis: the Centre's defence, price gaps, hospital arguments, the delay in the cap and the scope of price control.
No real disagreement between sides in this coverage.
Why: Backs price regulation and patient protection against private hospital profiteering, a state-led welfare angle; the Union government is shown as unable to answer the court's questions. Mostly court-reporting.
Why: Stresses state regulation of drug prices and price caps to protect patients from manufacturer profiteering; welfare and state-led framing leans left, though mostly court-reported and moderate.
Why: Court's rebuke of delayed price caps and private hospital profiteering favours state regulation and patient protection; welfare-leaning on statism, with few religion or identity signals. Mild lean left.
Why: Centre's light-touch pricing policy is shown failing consumers; court's pro-regulation, consumer-protection stance dominates. Touches statism (welfare/regulation vs market), so mild left lean; no religion or caste content.
Why: Court-hearing report foregrounds judges' sharp criticism of the Centre's market-led drug pricing and 'loot' remarks; welfare-over-market framing and the headline lean left, with little government voice beyond the ASG's defence.
Why: Backs state price control over pharma margins and frames market pricing as 'loot' hurting patients. Touches statism only, leaning welfare and regulation. Critical of the Centre through the court's remarks.
Why: Backs price caps and state regulation of drug and hospital margins, with sharp criticism of 'capitalistic thinking'. Welfare and statism lean left; the Centre's side gets one line.
Why: Court's sharp questions on drug pricing lean towards state regulation and patient welfare over industry, a mild statist-left signal; Centre's reply is included, so the score stays near centre.
Critical, Neutral or Supportive, scored separately. It refers to the Union government unless the story is about a state. On the spectrum strip, each dot is an article: its position is the ideology score and its colour is the stance.
If an article would score differently with the parties' roles reversed, that signal is partisanship. It goes into the stance tag, not the ideology score.
High, Medium or Low, based on how much of the article was read, how many clear signals it has, and whether they agree.
Stories with fewer than five articles are marked. A blindspot is a contested story where we found coverage from only one side.
Articles that touch none of the three dimensions, such as a car launch or a match report, carry no ideology score.
This prototype is refreshed by hand (last on 17 Oct, 03:00 IST). At launch:
| Wires and the top 20 outlets | checked every 5 minutes |
| All other outlets | checked every 15 minutes |
| New story | goes up at 3 articles from 2 or more outlets, marked Limited coverage |
| Live stories | new articles added every 15 minutes; summary rewritten at most hourly |
| Home page order | every 15 minutes |
New facts go into a dated update log at the top of the story. New articles carry an “Added” tag. If a note or list changes, the earlier version stays viewable.
A story is Live while coverage arrives, Winding down after about 2 days without new coverage, and Archived after about 7. Nothing is deleted: links never change, archived scores are frozen, and stories stay on their issue pages and in search.
NDTV, India Today, Times of India, Hindustan Times, The Hindu, Indian Express, News18, ABP, Times Now and Mint block the reader used for this prototype, so their articles are missing. Each story shows how many of India’s 15 largest outlets we read. The launch pipeline will read outlets’ public feeds, TV transcripts and Hindi articles.
Editor-in-charge: S. Kalra, editor@thenazariya.com. The editor-in-charge sets Nazariya's editorial rules, reviews the AI desks' daily decisions, and is responsible for everything we publish.
How we work: AI reads and scores every article against our published rubric; an AI standards desk checks accuracy and fairness; people set the rules, review decisions and handle complaints.
Grievance officer under the IT Rules, 2021: to be confirmed (based in India). Until then, write to grievance@thenazariya.com. Complaints are acknowledged within 24 hours and resolved within 15 days. To report a factual error: corrections@thenazariya.com. Other questions: support@thenazariya.com.
Ownership: Nazariya is independently owned by S. Kalra, an Indian citizen.
Funding: Nazariya is currently funded entirely by its founder. It carries no advertising and takes no money from any political party, government or party-linked organisation. In future it will be supported by optional reader memberships. Any other funder, grant or investor will be listed here, with the amount and date.
Independence: No owner, funder or member can change a story, a score or a correction. Scores follow the published rubric, and anyone can appeal them.
Anyone, including the outlet that published an article, can appeal a score: tap any score on a story page, then "Appeal this score" to write to the editor. Outlets can also dispute a summary. The editor reviews every appeal, and any change is recorded below. Appeals: appeals@thenazariya.com.
No detail that could identify a child or a survivor of sexual violence (Juvenile Justice Act, POCSO, BNS section 72). Court cases are reported as what was said and alleged. No analysis of a poll in the 48 hours before voting there (Representation of the People Act, section 126). Press Council and NBDSA norms on communal incidents.